Alvotech (NASDAQ:ALVOW – Get Free Report) was the recipient of a significant growth in short interest in February. As of February 27th, there was short interest totaling 1,444 shares, a growth of 20.8% from the February 12th total of 1,195 shares. Based on an average daily trading volume, of 3,204 shares, the short-interest ratio is presently 0.5 days. Based on an average daily trading volume, of 3,204 shares, the short-interest ratio is presently 0.5 days.
Alvotech Stock Performance
Shares of ALVOW stock opened at $0.30 on Tuesday. The firm has a fifty day moving average of $0.42 and a 200-day moving average of $0.84. Alvotech has a 52-week low of $0.15 and a 52-week high of $3.00.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Read More
- Five stocks we like better than Alvotech
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
